Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relamorelin in Diabetic Gastroparesis
NCT03383146Phase 3Terminated
- Sponsor
- Allergan
- Start
- Feb 2018
- Primary completion
- Nov 2020
- Modality
- Peptides, Small Molecules
- Countries
- 27
01
Overview
A Phase 3 trial of relamorelin in diabetic gastroparesis, sponsored by Allergan. Started Feb 2018; status: terminated.
02
Drugs
relamorelin
03
Conditions
diabetic gastroparesis
Beyond the preview
Go deeper on NCT03383146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03383146.